ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
Kezar Life Sciences Inc

Kezar Life Sciences Inc (KZR)

6.86
0.29
(4.41%)
終了 1月6日 6:00AM
6.87
0.01
(0.15%)
取引時間後: 9:59AM
高度なチャート

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
6.86
買値
6.79
売値
6.93
出来高
25,109
6.50 日の範囲 6.9311
5.016 52 週間の範囲 11.35
時価総額
前日終値
6.57
始値
6.5707
最終取引時間
財務取引量
US$ 168,728
VWAP
6.7198
平均取引量 (3 か月)
144,759
発行済株式数
7,296,222
配当利回り
-
PER
-0.49
1 株当たり利益 (EPS)
-13.96
歳入
7M
純利益
-101.87M

Kezar Life Sciences Inc について

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program. Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program.

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Kezar Life Sciences Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker KZR. The last closing price for Kezar Life Sciences was US$6.57. Over the last year, Kezar Life Sciences shares have traded in a share price range of US$ 5.016 to US$ 11.35.

Kezar Life Sciences currently has 7,296,222 shares in issue. The market capitalisation of Kezar Life Sciences is US$47.94 million. Kezar Life Sciences has a price to earnings ratio (PE ratio) of -0.49.

KZR 最新ニュース

Kezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update

Topline data from PORTOLA Phase 2a clinical trial evaluating zetomipzomib in patients with autoimmune hepatitis (AIH) expected in first half 2025 Cash, cash equivalents and marketable securities...

Kezar Life Sciences Announces 1-for-10 Reverse Stock Split

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that...

Kezar Board Unanimously Rejects Unsolicited Concentra Proposal and Adopts Limited Duration Stockholder Rights Plan

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.01-0.1455604075696.876.876.48477526.67995655CS
4-0.24-3.380281690147.17.16.16465466.63368222CS
12-1.651-19.39842556698.5118.9476.161447597.7456053CS
261.0718.48013816935.799.185.0165096347.28770497CS
52-2.64-27.78947368429.511.355.0165794457.94067457CS
156-162.34-95.9456264775169.2185.55.01682654952.50321459CS
260-27.94-80.287356321834.8185.55.01668326461.14149409CS

KZR - Frequently Asked Questions (FAQ)

What is the current Kezar Life Sciences share price?
The current share price of Kezar Life Sciences is US$ 6.86
How many Kezar Life Sciences shares are in issue?
Kezar Life Sciences has 7,296,222 shares in issue
What is the market cap of Kezar Life Sciences?
The market capitalisation of Kezar Life Sciences is USD 47.94M
What is the 1 year trading range for Kezar Life Sciences share price?
Kezar Life Sciences has traded in the range of US$ 5.016 to US$ 11.35 during the past year
What is the PE ratio of Kezar Life Sciences?
The price to earnings ratio of Kezar Life Sciences is -0.49
What is the cash to sales ratio of Kezar Life Sciences?
The cash to sales ratio of Kezar Life Sciences is 7.16
What is the reporting currency for Kezar Life Sciences?
Kezar Life Sciences reports financial results in USD
What is the latest annual turnover for Kezar Life Sciences?
The latest annual turnover of Kezar Life Sciences is USD 7M
What is the latest annual profit for Kezar Life Sciences?
The latest annual profit of Kezar Life Sciences is USD -101.87M
What is the registered address of Kezar Life Sciences?
The registered address for Kezar Life Sciences is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Kezar Life Sciences website address?
The website address for Kezar Life Sciences is kezarlifesciences.com
Which industry sector does Kezar Life Sciences operate in?
Kezar Life Sciences operates in the PHARMACEUTICAL PREPARATIONS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
US$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
337.5M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
230.01M

KZR 財務

財務

KZR Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock